AstraZeneca’s Truqap Demonstrates Phase 3 Success in Prostate Cancer
AstraZeneca’s Truqap (capivasertib) has achieved a significant milestone in the treatment of prostate cancer. Results from the CAPItello-281 Phase III
Read more
Drug Development
Generate and Novartis Forge $1B+ Alliance for AI-Powered Protein Therapeutics
AI firm Generate:Biomedicines announced on Tuesday that it has secured a $1B+ collaboration with Novartis to advance AI-driven protein therapeutics.
Read more
Sangamo and Genentech to Develop Genomic Medicines for Neurodegenerative Diseases
Sangamo Therapeutics Enters License Agreement with Genentech to Develop Genomic Medicines for Neurodegenerative Diseases Sangamo Therapeutics, Inc., a leader in
Read more
Sanofi, Formation Bio and OpenAI Forge First-in-class AI Collaboration
In a forward-thinking move, Sanofi, Formation Bio, and OpenAI have joined forces to harness the power of artificial intelligence in
Read more
Takeda Inks $2.2 Billion License Deal for AC Immune’s Alzheimer’s Immunotherapy
Takeda has secured an exclusive global option and license agreement for AC Immune’s promising active immunotherapy targeting amyloid beta for
Read more
Ventus’ NLRP3 Inhibitor Shows Potential for CNS Diseases in Phase 1 Trial
Ventus Therapeutics, a US-based clinical-stage biopharmaceutical company leveraging its exclusive structural biology and computational chemistry platform, ReSOLVE™, has disclosed promising
Read more
Vertex Expands Immunotherapy Capabilities with $4.9bn Alpine Acquisition
Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc., a biotechnology firm dedicated to pioneering protein-based immunotherapies, jointly announced the signing
Read more
Pfizer’s ABRYSVO® Shows Promising Results in Phase 3 Trial Targeting RSV Prevention in High-Risk Adults
Pfizer has announced encouraging findings from its ongoing pivotal Phase 3 clinical trial, known as MONeT (RSV IMmunizatiON Study for
Read more
EScalate Assay Enables Robust and Accurate Determination of Plasma Protein Binding
Determination of the Plasma Protein Binding of Liraglutide Using the EScalate* Equilibrium Shift Assay A Sovicell White Paper Evaluation of
Read more
Fluorescence Cross-Correlation Spectroscopy in Drug Discovery & Development
The use of Fluorescence Cross-Correlation Spectroscopy (FCCS) in Drug Discovery and Development An Intana Bioscience .pdf Case Study/Presentation The .pdf
Read more